PGGM Investments’s Idexx Laboratories IDXX Stock Holding History

PGGM Investments’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,037	Closed	-$1.27M	–	206
2025 Q1	$1.27M	Hold	3,037	–	–	0.02%	295
2024 Q4	$1.26M	Hold	3,037	–	–	0.02%	295
2024 Q3	$1.53M	Hold	3,037	–	–	0.02%	277
2024 Q2	$1.48M	Hold	3,037	–	–	0.02%	278
2024 Q1	$1.64M	Buy	3,037 +446	+17%	+$244K	0.02%	275
2023 Q4	$1.44M	Sell	2,591 -100	-4%	-$46.9K	0.02%	282
2023 Q3	$1.18M	Buy	2,691 +457	+20%	+$228K	0.02%	295
2023 Q2	$1.12M	Buy	2,234 +445	+25%	+$213K	0.02%	305
2023 Q1	$895K	Buy	+1,789	New	+$856K	0.02%	348
2022 Q1	$34.1M	Hold	51,776	–	–	0.17%	133
2021 Q4	$34.1M	Hold	51,776	–	–	0.17%	133
2021 Q3	$32.2M	Buy	51,776 +781	+2%	+$525K	0.17%	155
2021 Q2	$32.2M	Sell	50,995 -285	-0.6%	-$157K	0.14%	163
2021 Q1	$25.1M	Buy	51,280 +20,473	+66%	+$10.3M	0.11%	196
2020 Q4	$15.4M	Buy	+30,807	New	+$13.8M	0.07%	240

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PGGM Investments's IDXX Position: Q2 2025 in Review

PGGM Investments sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 3,037 shares — an estimated $1.27M sold.

PGGM Investments first reported a position in IDXX in Q4 2020 and held it in 15 quarters. The position peaked at $34.1M in Q1 2022. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

PGGM Investments reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
PGGM Investments sold 3,037 Idexx Laboratories shares in Q2 2025, an estimated $1.27M.
PGGM Investments first reported a position in Idexx Laboratories in Q4 2020 and held it in 15 quarters.
PGGM Investments's Idexx Laboratories position peaked at $34.1M in Q1 2022.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on PGGM Investments's 13F filing for Q2 2025, filed 18 Jul 2025.